[go: up one dir, main page]

AU2002321903A1 - Molecular interactions in cells - Google Patents

Molecular interactions in cells

Info

Publication number
AU2002321903A1
AU2002321903A1 AU2002321903A AU2002321903A AU2002321903A1 AU 2002321903 A1 AU2002321903 A1 AU 2002321903A1 AU 2002321903 A AU2002321903 A AU 2002321903A AU 2002321903 A AU2002321903 A AU 2002321903A AU 2002321903 A1 AU2002321903 A1 AU 2002321903A1
Authority
AU
Australia
Prior art keywords
cells
molecular interactions
interactions
molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002321903A
Other languages
English (en)
Inventor
Deanna Marie Carrick
Peter S. Lu
Joshua D. Rabinowitz
Johannes Schweizer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arbor Vita Corp
Original Assignee
Arbor Vita Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Vita Corp filed Critical Arbor Vita Corp
Publication of AU2002321903A1 publication Critical patent/AU2002321903A1/en
Priority to AU2003291558A priority Critical patent/AU2003291558B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002321903A 2001-08-03 2002-08-02 Molecular interactions in cells Abandoned AU2002321903A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003291558A AU2003291558B2 (en) 2001-08-03 2003-11-14 Molecular interactions in neurons

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30984101P 2001-08-03 2001-08-03
US60/309,841 2001-08-03
US36006102P 2002-02-25 2002-02-25
US60/360,061 2002-02-25
PCT/US2002/024655 WO2003014303A2 (fr) 2001-08-03 2002-08-02 Interactions moleculaires dans les cellules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2003291558A Division AU2003291558B2 (en) 2001-08-03 2003-11-14 Molecular interactions in neurons

Publications (1)

Publication Number Publication Date
AU2002321903A1 true AU2002321903A1 (en) 2003-02-24

Family

ID=26977039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002321903A Abandoned AU2002321903A1 (en) 2001-08-03 2002-08-02 Molecular interactions in cells

Country Status (4)

Country Link
EP (1) EP1443951A4 (fr)
AU (1) AU2002321903A1 (fr)
CA (1) CA2457424A1 (fr)
WO (1) WO2003014303A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6942981B1 (en) 1999-05-14 2005-09-13 Arbor Vita Corporation Method of determining interactions with PDZ-domain polypeptides
WO2002058450A2 (fr) 2000-12-22 2002-08-01 Dana-Faber Cancer Institute, Inc. Regulation de la proliferation cellulaire par muc1
AU2003291558B2 (en) * 2001-08-03 2009-08-13 Arbor Vita Corporation Molecular interactions in neurons
WO2004045535A2 (fr) * 2002-11-14 2004-06-03 Arbor Vita Corporation Interactions moleculaires dans des neurones
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
WO2004076646A2 (fr) * 2003-02-27 2004-09-10 Arbor Vita Corporation Methodes et compositions destinees a traiter le cancer du col uterin
KR20060037244A (ko) * 2003-05-02 2006-05-03 스코티쉬 바이오메디컬 리미티드 소형 GTPase들의 Rap과에 속하는 단백질에 대한구아닌 염기 교환 인자의 조절
WO2004108142A2 (fr) * 2003-06-06 2004-12-16 The University Of Manchester Traitement d'etats lies au vieillissement
EP1995256A1 (fr) * 2003-07-30 2008-11-26 University of Pittsburgh of the Commonwealth System of Higher Education Agonistes d'épitope de cellule T EPHA2 T et utilisations correspondantes
US8129506B2 (en) 2003-10-24 2012-03-06 Genzyme Corporation Modulation of the interaction of MUC1 with MUC1 ligands
EP1708745B1 (fr) 2003-12-23 2012-04-18 Arbor Vita Corporation Anticorps pour des souches oncogenes du hpv et leurs methodes d'utilisation
US7858322B2 (en) 2003-12-23 2010-12-28 Nono, Inc. Method of determining inhibition of binding to TRPM7 protein
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
CN101291683B (zh) * 2004-11-24 2011-08-17 纽普罗研究有限公司 治疗疾病的方法和组合物
EP2289535B8 (fr) 2004-12-21 2018-08-08 MUSC Foundation for Research Development Compositions et procédés pour la promotion de la cicatrisation de plaies et de la régénération de tissus
US9408381B2 (en) 2004-12-21 2016-08-09 Musc Foundation For Research Development Alpha Connexin c-Terminal (ACT) peptides for use in transplant
DE102005022182A1 (de) * 2005-05-09 2006-11-16 Combinature Biopharm Ag Modulatoren der PDZ-Domäne
JP2009503439A (ja) * 2005-07-01 2009-01-29 アルボー ビータ コーポレーション ウイルス感染および細菌感染の診断および処置のための方法および組成物
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
US8633160B2 (en) 2005-12-30 2014-01-21 Nono Inc. Small molecule inhibitors of PDZ interactions
US7972870B2 (en) 2007-02-02 2011-07-05 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3
WO2008097844A2 (fr) 2007-02-02 2008-08-14 Dana -Farber Cancer Institute, Inc. Méthodes et compositions associées à la régulation de l'apoptose par des protéines muc1 et des protéines pro-apoptotiques contenant seulement le domaine bh3
PL2320927T3 (pl) * 2008-07-09 2016-02-29 Univ Copenhagen Modyfikowane peptydy jako potencjalne inhibitory w reakcjach receptorów PSD 95 i NMD
RU2657535C2 (ru) 2012-03-01 2018-06-14 Ферстстринг Рисерч, Инк. Гели для местного применения, содержащие с-концевые пептиды альфа-коннексина (act)
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
US20160166637A1 (en) * 2013-08-02 2016-06-16 Virginia Tech Intellectual Properties, Inc. Methods of treating a cancer through targeted disruption of alpha connexin 43-zonula occludens-1 (zo-1) interaction
EP3074030A4 (fr) * 2013-11-26 2017-08-16 Trustees of Dartmouth College Procédé permettant d'atténuer ou de soulager des déficits synaptiques et cognitifs
JP6683686B2 (ja) 2014-08-22 2020-04-22 オークランド ユニサービシーズ リミティド チャネル調節剤
EA039314B1 (ru) 2017-07-05 2022-01-12 Биоселз (Бейдзин) Биотек Ко., Лтд. Фармацевтически приемлемые соли полипептидов и их применение
CA3196342A1 (fr) 2020-10-22 2022-04-28 Gautam Ghatnekar Formulations peptidiques et utilisations ophtalmiques associees

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976819A (en) * 1995-11-21 1999-11-02 National Jewish Medical And Research Center Product and process to regulate actin polymerization in T lymphocytes
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
WO2000031124A2 (fr) * 1998-11-20 2000-06-02 Mount Sinai Hospital Peptides modulant l'interaction des ephrines de classe b avec les domaines pdz
EP1178817A2 (fr) * 1999-05-14 2002-02-13 Arbor Vita Corporation Interactions moleculaires dans les cellules hematopoietiques

Also Published As

Publication number Publication date
EP1443951A4 (fr) 2006-05-03
CA2457424A1 (fr) 2003-02-20
EP1443951A2 (fr) 2004-08-11
WO2003014303A2 (fr) 2003-02-20
WO2003014303A3 (fr) 2003-08-14

Similar Documents

Publication Publication Date Title
AU2002321903A1 (en) Molecular interactions in cells
AU2002239336A1 (en) Molecular interactions in hematopoietic cells
AU2001270819A1 (en) Polymer electrolyte
AU2001258394A1 (en) Weather-resistant polymer blends
AU2003223244A1 (en) Molecular switches and methods for making and using the same
AUPQ520600A0 (en) Improvements in electrolysis cells
AUPS198302A0 (en) Improvements in bowsprits
AU2002215354A1 (en) Molecular interactions in hematopoietic cells
AU2002240892A1 (en) Protein-protein interactions in adipocyte cells
AU2002343025A1 (en) Improvements in footwear
AU2002301358A1 (en) Improvements in Transmissometers
AU2002301354A1 (en) Improvements in Transmissometers
AU2003234023A1 (en) Improvements in loudspeakers
AU2001286809A1 (en) Genes expressed in the cell cycle
AU5269800A (en) Molecular interactions in allergy cells
AUPR968801A0 (en) Improvements in enzyme stability
AU2002350591A1 (en) Electrochemical half cell
AU2002256468A1 (en) Molecular memory cell
AU2002343038A1 (en) Improvements in keyboards
AU2002363030A1 (en) Electrochemical half cell
AU2002256572A1 (en) Improvements in enzyme stability
AUPR968901A0 (en) Improvements in enzyme stability
AUPR553201A0 (en) Improvements in enzyme stability
AUPR808601A0 (en) Improvements in levels
AUPQ519700A0 (en) Elecrolytic cell

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase